Electrochemical strategies for the detection of cTnI. Issue 18 (24th August 2021)

• Record Type: Journal Article
• Authors: Yuan, Zhipeng; Wang, Li; Chen, Jun; Su, Weiguang; Li, Anqing; Su, Guosheng; Liu, Pengbo; Zhou, Xiangxiang
• Is Part Of: Analyst. Volume 146:Issue 18(2021)
• Page Start: 5474
• Page End: 5495
• Publication Date: 2021-08-24
• Subjects: Chemistry, Analytic -- Periodicals; 543
• DOI: 10.1039/d1an00808k
• Languages: English
• ISSNs: 0003-2654

Abstract

Abstract : Here, we organize all the pictures that appear in the text separately. Abstract : Acute myocardial infarction (AMI) is the main cause of death from cardiovascular diseases. Thus, early diagnosis of AMI is essential for the treatment of irreversible damage from myocardial infarction. Traditional electrocardiograms (ECG) cannot meet the specific detection of AMI. Cardiac troponin I (cTnI) is the main biomarker for the diagnosis of myocardial infarction, and the detection of cTnI content has become particularly important. In this review, we introduced and compared the advantages and disadvantages of various cTnI detection methods. We focused on the analysis and comparison of the main indicators and limitations of various cTnI biosensors, including the detection range, detection limit, specificity, repeatability, and stability. In particular, we pay more attention to the application and development of electrochemical biosensors in the diagnosis of cardiovascular diseases based on different biological components. The application of electrochemical microfluidic chips for cTnI was also briefly introduced in this review. Finally, this review also briefly discusses the unresolved challenges of electrochemical detection and the expectations for improvement in the detection of cTnI biosensing in the future.